Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

BTOG 2026 | Multidisciplinary approaches to lung cancer care in England’s NHS

Alastair Greystoke, PhD, MBChB, MRCP, Newcastle University, Newcastle, UK, highlights the value of bringing together a multidisciplinary community to deliver care for patients with lung cancer in England, highlighting the challenges and opportunities in the current NHS environment, including the uptake of screening and liquid biopsy services. Prof. Greystoke emphasizes the importance of sharing learnings and experiences to adapt pathways and address challenges. This interview took place at the 2026 British Thoracic Oncology Group (BTOG) congress in Edinburgh, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

The highlight for me from attending BTOG, as always, is bringing together the multidisciplinary community to work out how we can best deliver care for our patients with lung cancer in England. We’re in slightly challenging times in terms of the NHS environment, but also very exciting with uptake in screening, the liquid biopsy service that we now deliver. And so bringing us all together to work, to share learnings and experience in how we can best adapt our pathways to deal with the challenges is to me the most exciting and influential thing I’ve taken...

The highlight for me from attending BTOG, as always, is bringing together the multidisciplinary community to work out how we can best deliver care for our patients with lung cancer in England. We’re in slightly challenging times in terms of the NHS environment, but also very exciting with uptake in screening, the liquid biopsy service that we now deliver. And so bringing us all together to work, to share learnings and experience in how we can best adapt our pathways to deal with the challenges is to me the most exciting and influential thing I’ve taken.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...